Target
Ketohexokinase
Ligand
BDBM342508
Substrate
n/a
Meas. Tech.
Enzyme Assay
IC50
>30000±n/a nM
Citation
 Zhang, XAbad, MCGibbs, ACKuo, GSong, FSui, ZKuo, LC Indazole compounds useful as ketohexokinase inhibitors US Patent  US9771375 Publication Date 9/26/2017 
Target
Name:
Ketohexokinase
Synonyms:
Hepatic fructokinase | KHK | KHK_HUMAN | Ketohexokinase | Ketohexokinase (KHK) | Ketohexokinase (KHK) Isoform C
Type:
Enzyme Catalytic Domain
Mol. Mass.:
32521.64
Organism:
Homo sapiens (Human)
Description:
n/a
Residue:
298
Sequence:
MEEKQILCVGLVVLDVISLVDKYPKEDSEIRCLSQRWQRGGNASNSCTVLSLLGAPCAFMGSMAPGHVADFLVADFRRRGVDVSQVAWQSKGDTPSSCCIINNSNGNRTIVLHDTSLPDVSATDFEKVDLTQFKWIHIEGRNASEQVKMLQRIDAHNTRQPPEQKIRVSVEVEKPREELFQLFGYGDVVFVSKDVAKHLGFQSAEEALRGLYGRVRKGAVLVCAWAEEGADALGPDGKLLHSDAFPPPRVVDTLGAGDTFNASVIFSLSQGRSVQEALRFGCQVAGKKCGLQGFDGIV
  
Inhibitor
Name:
BDBM342508
Synonyms:
6-(1-Azetidin-3-yl-piperidin-4-ylmethyl)-3-methyl-1-phenyl-1H-pyrazolo[3,4-d]pyrimidin-4-ol | US9771375, Example 90
Type:
Small organic molecule
Emp. Form.:
C21H26N6O
Mol. Mass.:
378.4707
SMILES:
Cc1nn(-c2ccccc2)c2nc(CC3CCN(CC3)C3CNC3)nc(O)c12
Structure:
Search PDB for entries with ligand similarity: